PE investments in healthcare continued to both expand and mature in 2021, as firms look to position themselves on the right side of change in an industry that accounted for nearly 20% of US GDP in 2020. The shock waves of the COVID-19 pandemic have both benefited and stymied growth in the healthcare sector. Some […]
PE Healthcare Investments Mature in an Uncertain Year for Health Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Welsh Carson Targets $5B for New Buyout Fund Read More »
Welsh Carson Anderson & Stowe is back on the fundraising trail with a goal of collecting at least $5 billion to invest in healthcare and technology companies, Connecticut Retirement Plans and Trust Funds documents show. The firm hasn’t set an upper limit for the latest fund, WCAS XIV LP, and expects to hold a first
Welsh Carson Targets $5B for New Buyout Fund Read More »
Twin Brook Capital Partners (“Twin Brook” or the “Firm”), the middle market direct lending subsidiary of Angelo Gordon, today announced that it committed $3.5 billion to private equity sponsors in support of healthcare transactions last year, completing 60 healthcare transactions across 33 subsectors. The Firm served as lead agent on nearly all the healthcare transactions
You are unauthorized to view this page.
Corporate Investors Reshape Healthcare Industry Read More »
Private equity funding in healthcare has reached record highs, fueling growth across multiple sectors of the industry as regulators seek more information about their investments. PE firms’ primary target has been home health and outpatient care, with the number of related buyouts more than doubling from 2016 to 2020, according to a recent white paper.
Corporate Investors Reshape Healthcare Industry Read More »
KKR, a leading global investment firm, today announced the final closing of KKR Health Care Strategic Growth Fund II (“HCSG II” or the “Fund”), a $4.0 billion fund dedicated to health care growth equity investment opportunities primarily in North America and Europe. With a diversified portfolio approach, HCSG II will focus on the biopharmaceutical, medical
KKR Closes $4B Health Care Strategic Growth Fund II Read More »
You are unauthorized to view this page.
KKR Closes $4B Health Care Strategic Growth Fund II Read More »
Venture investment in healthcare reached new heights in 2021, with more than $80 billion invested in biopharma, medical device, diagnostics/tools (dx/tools) and healthtech companies, according to Silicon Valley Bank’s annual Healthcare Investments and Exits Report. The more than 30% increase over 2020’s record is punctuated by a banner first half of the year. Read the
Silicon Valley Bank’s Healthcare Report Shows Record Venture Investment in 2021 Read More »
